The CYP1A2 Genotype Modifies the Association Between Coffee Consumption and Breast Cancer Risk Among BRCA1 Mutation Carriers
Open Access
- 1 May 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 16 (5), 912-916
- https://doi.org/10.1158/1055-9965.epi-06-1074
Abstract
We have recently reported that, among BRCA1 mutation carriers, the consumption of caffeinated coffee was associated with a significant reduction in breast cancer risk. Because the metabolism of caffeine is primarily by CYP1A2, we examined whether or not the CYP1A2 genotype modifies the association between a history of coffee consumption and the risk of breast cancer. A common A to C polymorphism in the CYP1A2 gene is associated with decreased enzyme inducibility and impaired caffeine metabolism. Information regarding coffee consumption habits and the CYP1A2 genotype was available for 411 BRCA1 mutation carriers (170 cases and 241 controls). We estimated the odds ratios (ORs) and 95% confidence intervals (95% CIs) for breast cancer associated with the CYP1A2 genotype and a history of coffee consumption before age 35, adjusting for potential confounders. The CYP1A2 genotype did not affect breast cancer risk. Among women with at least one variant C allele (AC or CC), those who consumed coffee had a 64% reduction in breast cancer risk, compared with women who never consumed coffee (OR, 0.36; 95% CI, 0.18-0.73). A significant protective effect of coffee consumption was not observed among women with the CYP1A2 AA genotype (OR, 0.93; 95% CI, 0.49-1.77). Similar results were obtained when the analysis was restricted to caffeinated coffee. This study suggests that caffeine protects against breast cancer in women with a BRCA1 mutation and illustrates the importance of integrating individual genetic variability when assessing diet-disease associations. (Cancer Epidemiol Biomarkers Prev 2007;16(5):912–6)Keywords
This publication has 29 references indexed in Scilit:
- Population-based case–control study of AhR (aryl hydrocarbon receptor) and CYP1A2 polymorphisms and breast cancer riskPharmacogenetics and Genomics, 2006
- Estrogen Metabolism–Related Genes and Breast Cancer Risk: The Multiethnic Cohort StudyCancer Epidemiology, Biomarkers & Prevention, 2005
- Association of Genetic Polymorphisms with Serum Estrogens Measured Multiple Times During a 2-Year Period in Premenopausal WomenCancer Epidemiology, Biomarkers & Prevention, 2005
- CYP1A2 phenotype and genotype in a population from the Carboniferous Region of Coahuila, MexicoToxicology Letters, 2005
- Prevention and Management of Hereditary Breast CancerJournal of Clinical Oncology, 2005
- BRCA1 Induces Antioxidant Gene Expression and Resistance to Oxidative StressCancer Research, 2004
- Functional significance of a C→A polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeineBritish Journal of Clinical Pharmacology, 1999
- Association of coffee, green tea, and caffeine intakes with serum concentrations of estradiol and sex hormone‐binding globulin in premenopausal Japanese womenNutrition and Cancer, 1998
- Estrogens and breast cancerCarcinogenesis: Integrative Cancer Research, 1996
- Caffeine as an antioxidant: inhibition of lipid peroxidation induced by reactive oxygen speciesBiochimica et Biophysica Acta (BBA) - Biomembranes, 1996